After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
All eyes will be on Dynegy, PPL, NextEra and others in the sector with power prices down over last year in much of the U.S. and the Oncor sale pending.
Cramer likes Celgene despite the biotech sector's problems but is ringing the register on EMC.
Everyone wins in this battle as high-quality stocks become more attractive, Cramer says.
The group has performed like a champ this year as investors go for yield and a safe haven amid market uncertainty.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.